R. Gendreau
Chief Tech/Sci/R&D Officer chez VIRIOS THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
R.
Michael Gendreau is the founder of Cypress Bioscience, Inc. founded in 1981, where he held the position of Chief Medical Officer and VP-Research & Development from 1995 to 2011.
He is currently the Chief Medical Officer at Virios Therapeutics, Inc. since 2012 and at Cerephex Corp.
He has previously held the position of Chief Medical Officer and VP-Research & Development at Microprobe Corp.
from 1991 to 1994, Vice President-Research & Development at Source Scientific, Inc. in 1991, and Manager-Worldwide Health Care Technology at Battelle Memorial Institute from 1988 to 1988.
He was also the Chief Medical Officer at Intec Pharma Ltd.
from 2018 to 2020.
Dr. Gendreau received his undergraduate degree from The Ohio University and his doctorate from The Ohio State University College of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de R. Gendreau
| Sociétés | Poste | Début |
|---|---|---|
| VIRIOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/02/2012 |
Cerephex Corp.
 Cerephex Corp. Medical SpecialtiesHealth Technology Cerephex Corp. develops and provides therapies and diagnostic technologies for chronic centralized pain. It offers NeuroPoint, a point-of-care medical device that is built upon patented reduced impedance noninvasive cortical electrostimulation signal technology platform developed to unable use by physician-supervised staff in existing clinical outpatient offices. The company was founded by Jeffrey Hargrove and Robert M. Ford on September 26, 2012 and is headquartered in Los Altos, CA. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de R. Gendreau
| Sociétés | Poste | Fin |
|---|---|---|
Intec Pharma Ltd.
 Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Chief Tech/Sci/R&D Officer | 31/10/2020 |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Founder | 01/01/2011 |
Microprobe Corp.
 Microprobe Corp. Miscellaneous Commercial ServicesCommercial Services Microprobe Corp. is an American company that specializes in commercial medical research. | Chief Tech/Sci/R&D Officer | 01/01/1994 |
| Source Scientific, Inc. | Chief Tech/Sci/R&D Officer | 01/01/1991 |
Battelle Memorial Institute
 Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Corporate Officer/Principal | 01/01/1988 |
Formation de R. Gendreau
| The Ohio University | Undergraduate Degree |
| The Ohio State University College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIRIOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Microprobe Corp.
Microprobe Corp. Miscellaneous Commercial ServicesCommercial Services Microprobe Corp. is an American company that specializes in commercial medical research. | Commercial Services |
| Source Scientific, Inc. | Health Technology |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
Battelle Memorial Institute
Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Commercial Services |
Cerephex Corp.
Cerephex Corp. Medical SpecialtiesHealth Technology Cerephex Corp. develops and provides therapies and diagnostic technologies for chronic centralized pain. It offers NeuroPoint, a point-of-care medical device that is built upon patented reduced impedance noninvasive cortical electrostimulation signal technology platform developed to unable use by physician-supervised staff in existing clinical outpatient offices. The company was founded by Jeffrey Hargrove and Robert M. Ford on September 26, 2012 and is headquartered in Los Altos, CA. | Health Technology |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Health Technology |
